Mirati Therapeutics Stock Price, News & Analysis (OTCMKTS:MYLGF)

$6.07 0.00 (0.00 %)
(As of 02/25/2018 04:24 AM ET)
Previous Close$6.07
Today's RangeN/A
52-Week RangeN/A
Average Volume355 shs
Market Capitalization$70.20 million
P/E Ratio-86.71
Dividend YieldN/A

About Mirati Therapeutics (OTCMKTS:MYLGF)

MethylGene, Inc. operates as a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics for cancer and infectious disease.

Receive MYLGF News and Ratings via Email

Sign-up to receive the latest news and ratings for MYLGF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E Ratio-86.7142857142857
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPSN/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

Mirati Therapeutics (OTCMKTS:MYLGF) Frequently Asked Questions

What is Mirati Therapeutics' stock symbol?

Mirati Therapeutics trades on the OTCMKTS under the ticker symbol "MYLGF."

Who are some of Mirati Therapeutics' key competitors?

Who are Mirati Therapeutics' key executives?

Mirati Therapeutics' management team includes the folowing people:

  • Martin Godbout Ph.D, Chairman of the Board (Age 57)
  • Charles M. Baum M.D., Ph.D., President, Chief Executive Officer, Director (Age 55)
  • Mark J. Gergen, Chief Operations Officer, Executive Vice President (Age 51)
  • Rachel W. Humphrey M.D., Chief Medical Officer, Executive Vice President (Age 51)
  • Jamie A. Donadio, Vice President - Finance (Age 38)
  • Henry J. Fuchs M.D., Ph.D., Independent Director (Age 55)
  • Rodney W. Lappe Ph.D., Independent Director (Age 58)
  • Peter A. Thompson M.D., Independent Director (Age 53)

How do I buy Mirati Therapeutics stock?

Shares of Mirati Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mirati Therapeutics' stock price today?

One share of Mirati Therapeutics stock can currently be purchased for approximately $6.07.

How big of a company is Mirati Therapeutics?

Mirati Therapeutics has a market capitalization of $70.20 million.

MarketBeat Community Rating for Mirati Therapeutics (MYLGF)

Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  112 (Vote Outperform)
Underperform Votes:  40 (Vote Underperform)
Total Votes:  152
MarketBeat's community ratings are surveys of what our community members think about Mirati Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Mirati Therapeutics (OTCMKTS:MYLGF) Analyst Ratings History

No equities research coverage for this company has been tracked by MarketBeat


Earnings History for Mirati Therapeutics (OTCMKTS:MYLGF)

No earnings announcements for this company have been tracked by MarketBeat.com


Mirati Therapeutics (OTCMKTS:MYLGF) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for Mirati Therapeutics (OTCMKTS:MYLGF)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Mirati Therapeutics (OTCMKTS MYLGF)

No insider trades for this company have been tracked by MarketBeat.com


Mirati Therapeutics (OTCMKTS MYLGF) News Headlines

No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Mirati Therapeutics (OTCMKTS:MYLGF) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Mirati Therapeutics (OTCMKTS MYLGF) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.